ampicillin has been researched along with pefloxacin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Hannan, A | 1 |
| Christiaens, JL; Derambure, P; Hladky, JP; Jomin, M; Lesoin, F; Leys, D; Petit, H; Rousseaux, M | 1 |
| Chang, HR; Pechère, JC; Vladoianu, IR | 1 |
| Chacon, JP; Criscuolo, PD; Ferraro, JR; Kobata, CM; Reis, C; Saad, SS | 1 |
| Campos, LC; dos Reis, EM; Ribeiro Dias, JC | 1 |
| Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
| Martin, E; Nauciel, C | 1 |
| Badoual, J; Bergeret, M; Chemillier-Truong, M; Gendrel, D; Habib, F; Iniguez, JL; Legall, MA; Moulin, F; Raymond, J | 1 |
| Bartoli, M; Cavallo, JD; Crenn, Y; Meyran, M; Nizou, JY | 1 |
| Arman, D; Tural, D; Willke, A | 1 |
| Kurmanova, KB; Sensatkhit, K; Sulełmenova, ZI; Uteulin, MN | 1 |
| Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
1 review(s) available for ampicillin and pefloxacin
| Article | Year |
|---|---|
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
2 trial(s) available for ampicillin and pefloxacin
| Article | Year |
|---|---|
Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections.
Topics: Adolescent; Adult; Ampicillin; Cholangitis; Cholecystitis; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Prospective Studies; Remission Induction | 1990 |
[Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas].
Topics: Aged; Ampicillin; Anti-Infective Agents; Antigens, CD; Drug Therapy, Combination; Erysipelas; Erythromycin; Female; Humans; Immunity, Cellular; Immunoglobulins; Male; Middle Aged; Patient Discharge; Pefloxacin; Penicillin G; Pyoderma; Staphylococcus aureus; Streptococcus pyogenes; T-Lymphocytes | 1997 |
15 other study(ies) available for ampicillin and pefloxacin
| Article | Year |
|---|---|
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Management of focal intracranial infections: is medical treatment better than surgery?
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Brain Abscess; Cause of Death; Ceftriaxone; Combined Modality Therapy; Empyema, Subdural; Female; Humans; Male; Metronidazole; Pefloxacin; Postoperative Complications; Suction; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Chloramphenicol; Humans; In Vitro Techniques; Macrophages; Pefloxacin; Salmonella Phages; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Trypan Blue | 1990 |
In vitro susceptibility of Salmonella to ciprofloxacin and pefloxacin compared with three other antibiotics.
Topics: Ampicillin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Pefloxacin; Salmonella; Salmonella typhimurium; Serotyping; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
[Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chloramphenicol; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Norfloxacin; Pefloxacin; Salmonella Infections, Animal; Salmonella typhimurium | 1987 |
[Failure of the treatment with antibiotics in severe Salmonella infections in children and use of quinolones].
Topics: Amoxicillin; Ampicillin; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Clavulanic Acids; Female; Humans; Infant; Male; Pefloxacin; Salmonella Infections; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
[In vitro bactericidal activity of seven antibiotics and four combinations against Neisseria meningitidis].
Topics: Ampicillin; Ceftriaxone; Chloramphenicol; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Neisseria meningitidis; Pefloxacin; Penicillin G; Rifampin; Spiramycin | 1994 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |